Terrill SJ, Jackson CM, Greene HE, Lilly N, Maske CB, Vallejo S et al
In large-scale studies, participants using semaglutide or tirzepatide under medical supervision saw average weight loss between 10% and 15% of their body weight over the course of a year
Batch-level COA documentation and exact country-of-origin per order are not publicly published and should be requested from support if relevant to your decision
Sleep Optimization First signs: Days 3-7 (deeper sleep, more vivid dreams, waking more rested) Consistent improvement: Week 2-3 (sleep architecture stabilizes at improved baseline) Peak benefit: Week 4-6 (maximum subjective sleep quality improvement) Key requirement: Good sleep hygiene baseline
Stabilize their bodys hormone levels
The vision loss is generally irreversible, and there is currently no effective treatment available